Quadria Capital makes investment in HCG’s Strand Life Sciences

12 Feb 2018 Evaluate

Quadria Capital a leading Asian healthcare focused private equity investor has made an investment in HealthCare Global Enterprises’ (HCG) Strand Life Sciences (Strand). The investment follows the previously announced combination of Triesta Sciences, a unit of HCG, and Strand, creating India’s leading specialized diagnostics player.  The investment by Quadria will fund the strategic expansion of Strand and the build out of a unique integrated platform dedicated to next generation precision medicine.

HealthCare Global Enterprises is the largest provider of cancer care in India. Through its network of 15 comprehensive cancer centres spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.

HealthcareGlobal Share Price

498.45 -0.15 (-0.03%)
15-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6694.40
Max Healthcare Inst 1039.35
Narayana Hrudayalay 1287.85
Aster DM Healthcare 489.85
Global Health 1023.35
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.